170811 ⎘
Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders; Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING
#2COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES
#3APPLICATION OF REAGENT FOR QUANTITATIVE DETECTION OF PYROGLUTAMYL AMINOPEPTIDASE IN THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
#4Proteomic Risk Score For Adjudicated Arthropathy (AA)
#5IGM ANTIBODIES DEGRADING IGG
#6METHOD FOR DETERMINING THE RESPONSE TO METHOTREXATE (MTX) IN A HUMAN SUBJECT DIAGNOSED WITH RHEUMATOID ARTHRITIS
#7BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY
#8BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE THERAPY WITHDRAWAL
#9IDENTIFICATION AND MEDICAL APPLICATIONS OF ANTI-CITRULLINATED-PROTEIN ANTIBODIES IN RHEUMATOID ARTHRITIS
#10BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE THERAPY
#11METHOD FOR DIAGNOSING COLLAGEN DEGRADATION ASSOCIATED DISEASE
#12FAB-LINKED GLYCANS AS BIOMARKER FOR THE TRANSITION FROM A PRE DISEASE "AT-RISK-PHASE" TO RHEUMATOID ARTHRITIS, AAV OR SJÖGREN SYNDROME
#13METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN
#14NSAID-DERIVED CONJUGATE COMPOUNDS FOR IMAGING
#15ANTIBODY DRUG FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES
#16TGF- B receptor II isoform, fusion peptide, methods of treatment and methods in vitro
#17BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY
#18TENASCIN-C AUTOANTIGENIC EPITOPES IN RHEUMATOID ARTHRITIS
#19ANTI-OX40L ANTIBODY, ANTI-OX40L/ANTI-TNFa BISPECIFIC ANTIBODY, AND USES THEREOF
#20Treatment of Inflammatory Conditions or Diseases
#21DIAGNOSTIC INDICATORS AND THERAPEUTIC TARGETS OF RHEUMATOID ARTHRITIS
#22DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#23BIOMARKERS FOR PREDICTING IMMUNOGENICITY AND THERAPEUTIC RESPONSES TO ADALIMUMAB IN RHEUMATOID ARTHRITIS PATIENTS
#24METHODS FOR SYSTEMATICALLY ASSESSING LOCAL INFLAMMATION AND ACTIVE REPAIR
#25BACTERIAL BIOMARKER FOR RHEUMATOID ARTHRITIS AND RELATED MATERIALS AND METHODS
#26IMMUNOASSAYS FOR HIGH POSITIVELY CHARGED PROTEINS
#27TEST METHOD AND TEST KIT FOR ADULT STILL'S DISEASE
#28METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS
#29ANTIBODY ANTI IL17
#30Dissolved Protein Arthritis Markers
#31MOLECULAR DISEASE PROFILE AND USE THEREOF FOR MONITORING AND TREATING RHEUMATAOID ARTHRITIS
#32Methods for predicting response to treatment
#33COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS
#34COMPOSITION FOR PREVENTING OR ALLEVIATING CELLULAR SENESCENCE
#35COMPOSITIONS AND METHODS FOR DIAGNOSING AND ASSESSING RHEUMATOID ARTHRITIS USING PROTEIN-ARGININE DEIMINASE 1 (PAD1) AUTOANTIGENS
#36METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#37METHODS FOR IDENTIFYING PATTERNS OF IFN INDUCED EXPRESSION AND USE IN DIAGNOSIS, MONITORING AND THERAPY
#38Diagnosis of autoimmune disease
#39DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#40Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#41Methods for Predicting Patient Response to DMARDs
#42Biomarker for diagnosing rheumatoid arthritis and uses thereof
#43REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT DISEASES
#44BIOMARKER FOR PREDICTING OR CLASSIFYING SEVERITY OF RHEUMATOID ARTHRITIS USING METABOLITE ANALYSIS
#45METHODS AND COMPOUNDS FOR TYPING RHEUMATOID FACTORS
#46BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY
#47METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITIS
#48EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
#49METHODS, ARRAYS AND USES THEREOF FOR DIAGNOSING OR DETECTING AN AUTOIMMUNE DISEASE
#50PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS
#51METHOD FOR ESTIMATING THE EFFECTIVENESS OF TREATMENT WITH AN ANTI-CD20 AGENT IN A PATIENT WITH RHEUMATOID ARTHRITIS AND HAVING HAD AN INADEQUATE RESPONSE TO AT LEAST ONE BIOTHERAPY
#5214-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#53BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE THERAPY
#54BIOMARKERS AND METHODS FOR MEASURING AND MONITORING AXIAL SPONDYLOARTHRITIS ACTIVITY
#55METHOD FOR ESTIMATING THE EFFECTIVENESS OF A TREATMENT BY AN ANTI-TNF ALPHA AGENT IN A PATIENT SUFFERING FROM RHEUMATOID ARTHRITIS AND HAVING AN INADEQUATE RESPONSE TO AT LEAST ONE BIOTHERAPY
#56ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
#57PROFILING OF RHEUMATOID ARTHRITIS AUTOANTIBODY REPERTOIRE AND PEPTIDE CLASSIFIERS THEREFOR
#58ASSESSING RESPONSIVENESS OF RHEUMATOID ARTHRITIS PATIENTS TO BIOLOGICAL TREATMENT
#59A METHOD OF DIAGNOSING OR PROGNOSING PSORIATIC ARTHRITIS
#60Rheumatoid arthritis auto-antibody-bound peptide and application thereof
#61COMPOSITIONS AND METHODS FOR CHARACTERIZING ARTHRITIC CONDITIONS
#62METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#63PREDICTION OF DRUG-FREE REMISSION IN RHEUMATOID ARTHRITIS
#64METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#65Identification of a T cell epitope of that induces T cell responses in patients with rheumatoid arthritis
#66Serum biomarkers for predicting and evaluating response to TNF inhibitor therapy in rheumatoid arthritis patients
#67COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES
#68BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE THERAPY WITHDRAWAL
#69KIT FOR MEASURING ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY, APPLICATION THEREOF, AND TEST METHOD
#70Methods of Preserving Blood Samples for Mass Screening to Detect at-Risk Individuals for Autoimmune Diseases
#71LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#72Detection of autoantibodies for diagnosing degenerative diseases of the skeletal system
#73Dissolved protein arthritis markers
#74Methods and products for evaluating an immune response to a therapeutic protein
#75METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#76Methods and Compositions for Modulating TH-GM Cell Function
#77METHODS AND KITS FOR EVALUATING CLINICAL OUTCOMES OF AUTOIMMUNE DISEASE
#78Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#79METHODS OF DETERMINING RESPONSE TO TNF ALPHA BLOCKERS
#80USE OF ANTI-CD26 ANTIBODY LEVELS AS AUTOIMMUNE AND/OR INFLAMMATORY DISEASE BIOMARKERS
#81Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis
#82NANOCARRIERS AND THEIR PROCESSING FOR DIAGNOSTICS AND THERAPEUTICS
#83Diagnosis and treatment of autoimmune diseases
#84METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#85Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis
#86BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY
#87Identification and monitoring of apoptosis inhibitor of macrophage
#88Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#89Methods for predicting response to treatment
#90METHOD FOR ESTIMATING THE EFFECTIVENESS AGAINST RHEUMATOID ARTHRITIS OF A T-LYMPHOCYTE CO-STIMULATION MODULATOR AGENT
#91MMP-8 AS A MARKER FOR IDENTIFYING INFECTIOUS DISEASE
#92Detection and treatment of autoimmune disorders
#93Methods for identifying candidate biomarkers
#94Methods for identifying a treatment for rheumatoid arthritis
#95Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in individual patients
#9614-3-3 Antagonists for the Prevention and Treatment of Arthritis
#97DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#98PROTEOGLYCAN IRREGULARITIES IN ABNORMAL FIBROBLASTS AND THERAPIES BASED THEREFROM
#99ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
#100Methods and compositions for treating subjects having rheumatoid arthritis
#101Methods and materials for assessing and treating arthritis
#102Method for treating rheumatoid arthritis
#103METHODS OF TREATING EARLY RHEUMATOID ARTHRITIS
#104DIAGNOSTIC MARKER FOR PREDICTING EFFICACY OF RA DRUG AND APPLICATION THEREOF
#105ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF
#106ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF
#107Pre-assembled, protected, chemically stable, chemoselective linkers
#108Fab-linked glycans as biomarker for the transition from a pre-disease “at-risk-phase” to rheumatoid arthritis; AAV or Sjögren syndrome
#109CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#110Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions
#111Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and Kawasaki disease
#112MULTIPLEX MEASURE OF ISOTYPE ANTIGEN RESPONSE
#113Identification and monitoring of cleaved immunoglobulins by molecular mass
#114Use of glycan as biomarkers for autoimmune diseases
#115Identification of a T cell epitope of that induces T cell responses in patients with Rheumatoid arthritis
#116Anti-IL17A autoantibodies for treating or reducing the likelihood of occurrence of bone destruction associated with a chronic autoimmune or inflammatory disease
#117MARKER SEQUENCES FOR MANAGING THE THERAPY OF RHEUMATOID ARTHRITIS PATIENTS
#118Diagnosis and treatment of autoimmune diseases
#119METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#120MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS
#121TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro
#122Method of diagnosing arthritis or other joint degrading disease
#123Diagnosis of autoimmune diseases
#124Biomarkers for Cell Therapy
#125Antibody facilitating programmed necrosis of cells and application thereof
#126METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT
#127Biomarkers and methods for assessing response to inflammatory disease therapy
#128Anti-carbamylated protein antibodies and the risk for arthritis
#129METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#130ATR-FTIR for non-invasive detection of colitis
#131METHODS AND MATERIALS FOR TREATING AUTOIMMUNE CONDITIONS
#132PEPTIDE AND BIOMARKER ASSOCIATED WITH INFLAMMATORY DISORDERS, AND USES THEREOF
#133Immunological signatures and parameters predicting therapeutic responses to anti-TNF therapy
#134Anti-surrogate light chain antibodies
#135Methods for identifying patterns of IFN induced expression and use in diagnosis, monitoring and therapy
#136MEANS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY DISORDERS
#137METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#138MEl'hods and means for diagnosing spondylarthritis using autoantibody markers
#139Biomarkers and methods for assessing psoriatic arthritis disease activity
#140Methods for assessing response to inflammatory disease therapy withdrawal
#141DEVICE, SYSTEM AND METHOD FOR MANAGING TREATMENT OF AN INFLAMMATORY AUTOIMMUNE DISEASE OF A PERSON
#142Nanocarriers and their processing for diagnostics and therapeutics
#143Autoantigens for diagnosis of rheumatoid arthritis
#144CXCL13 AS AN INDICATOR OF GERMINAL ACTIVITY AND IMMUNE RESPONSE
#145Dissolved protein arthritis markers
#146Methods and products for evaluating an immune response to a therapeutic protein
#147Optical probes for matrix metalloproteinases
#148Compositions and methods for the diagnosis of rheumatoid arthritis
#149BIOMARKERS FOR RHEUMATOID ARTHRITIS
#150METHOD FOR DIAGNOSING ARTHROSIS
#151Methods and materials for assessing and treating arthritis
#152Diagnosis of leukocyte-mediated disease and halogen gas exposure
#153Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-PIK3CD
#154DIFFERENTIAL DIAGNOSIS AND THERAPY SELECTION FOR RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
#155RHEUMATOID ARTHRITIS RELATED BIOMARKER
#156RHEUMATOID ARTHRITIS MARKER
#157Treatment Methods for Rheumatoid Arthritis
#158Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers
#159Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies
#160USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES
#161Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit
#162METHOD AND KIT FOR THE PREDICTIVE PROGNOSIS OF RESPONSIVENESS TO TREATMENTS OF AUTOIMMUNE DISEASES
#163Methods, agents and compositions for treatment of inflammatory conditions
#164COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#165Anti-carbamylated protein antibodies and the risk for arthritis
#166Methods and compositions for modulating T-GM cell function
#167Method for treating rheumatoid arthritis
#168Methods for treating medical conditions by anti-type 2 therapy
#169Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#170Method to optimize the treatment of patients with biological drugs
#171Biomarkers and methods for measuring and monitoring axial spondyloarthritis activity
#172Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#173Method for the serological diagnosis of rheumatoid arthritis
#174USE OF CTLA4 COMPOUND FOR ACHIEVING DRUG-FREE REMISSION IN SUBJECTS WITH EARLY RA
#175METHODS AND COMPOSITIONS FOR IDENTIFYING PATIENT POPULATIONS FOR DIAGNOSIS AND TREATMENT OF TLR4-DEPENDENT DISORDERS
#176Use of glycan as biomarkers for autoimmune diseases
#177METHODS AND SYSTEM FOR DETERMINING THE DISEASE STATUS OF A SUBJECT
#178Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
#179MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOF
#180Diagnostic and immunotherapy compositions and methods for disease states mediated by inhibitor-resistant CD8 T-cells
#181METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#182Compositions and methods to treat inflammatory joint disease
#183CXCR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#184Magnetic apparatus and methods of use
#185Biomarker and uses thereof
#186BIOMARKERS AND USES THEREOF
#187Method for detecting nucleosomes containing histone variants
#188Cyclic citrullinated peptide, rheumatoid arthritis diagnosis composition including the same, rheumatoid arthritis diagnosis method using the peptide or the composition, and method of screening diagnostic marker for rheumatoid arthritis
#189BIOMARKER FOR RHEUMATOID ARTHRITIS DIAGNOSIS OR ACTIVITY EVALUATION
#190Diagnosis and treatment of autoimmune diseases
#191Candidates against infection
#192Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin
#193Causative agents and diagnostic methods relating to rheumatoid arthritis
#194PREVOTELLA COPRI AND ENHANCED SUSCEPTIBILITY TO ARTHRITIS
#195METHODS FOR IDENTIFYING AUTOIMMUNE ARTHRITIS AND FOR SCREENING FOR INHIBITOR OF ACTIVATION OF AUTOIMMUNE ARTHRITOGENIC T CELLS
#196BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
#197Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#198Detection and treatment of autoimmune disorders
#199Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#200Computer systems for treating diseases
#201METHODS FOR PREDICTING RHEUMATOID ARTHRITIS TREATMENT RESPONSE
#202Test method for rheumatoid arthritis and kit for rheumatoid arthritis test
#203Compositions and methods for the diagnosis of rheumatoid arthritis
#204PERSONALISED MEDICINE
#205METHODS FOR DETECTING INFLAMMATORY DISORDERS
#206Diagnosis and Treatment of Arthritic Conditions
#20714-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#208Transgenic model for delay-type hypersensitivity (DTH) and use thereof
#209Methods for the treatment of autoimmune diseases
#210METABOLIC PROFILES
#211Application of N-terminomics to NETosis in inflammation
#212Method and kit for cytokine analysis from a human whole blood sample
#213Biomarkers and methods for measuring and monitoring inflammatory disease activity
#214Diagnosis Of Rheumatoid Arthritis
#215BIOMARKERS OF AUTOIMMUNE AND/OR CHRONIC DISEASES ASSOCIATED WITH JOINT INFLAMMATION
#216Methods for analyzing glycan-derived monosaccharides
#217METHOD TO IDENTIFY PATIENTS THAT WILL LIKELY RESPOND TO ANTI-TNF THERAPY
#218Methods of determining levels of cleaved and/or intact kininogen
#219Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies
#220Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#221METHODS FOR DIAGNOSING AND MONITORING DISEASE BY DIRECTLY QUANTIFYING DISEASE MODIFIED BIOMOLECULES
#222Pharmaceutical compositions comprising inhibitors of zinc-ZIP8-MTF1 as active ingredients for preventing or treating a joint disease
#223ASSAY METHOD
#224MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS
#225Methods for detecting antibodies
#226Nanocarriers and their processing for diagnostics and therapeutics
#227Methods of treating rheumatoid arthritis
#228Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
#229METHODS FOR IDENTIFYING PATTERNS OF IFN INDUCED EXPRESSION AND USE IN DIAGNOSIS, MONITORING AND THERAPY
#230METHOD FOR THE DIAGNOSIS OF EARLY RHEUMATOID ARTHRITIS
#231Detection of diagnostic peptides
#232Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
#233Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers
#234MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOF
#235Diagnosis kit for rheumatoid arthritis
#236Methods and products for evaluating an immune response to a therapeutic protein
#237Treatment methods for rheumatoid arthritis
#238DETECTION AND MODULATION OF RHEUMATOID ARTHRITIS
#239Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#240Methods for treating, diagnosing, and monitoring rheumatoid arthritis
#241Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#242TENASCIN-C AND USE THEREOF IN RHEUMATOID ARTHRITIS
#243VEGF-specific capture agents, compositions, and methods of using and making
#244Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus
#245Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject
#246Biomarkers for ankylosing spondylitis
#247Anti-carbamylated protein antibodies and the risk for arthritis
#248Methods for diagnosing degenerative joint disease
#249Fucoidans as ligands for the diagnosis of degenerative pathologies
#250Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
#251Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
#252Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease
#253Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#254Computer systems for treating diseases
#255Novel binding site of IKK-beta
#256Methods and means for diagnosing spondylarthritis using autoantibody markers
#257Detection and treatment of autoimmune disorders
#258Computer systems for treating diseases
#259Anti-FDP monoclonal antibody, FDP measurement reagent and reagent kit using same, and FDP measurement method
#260Reagent and reagent kit for measurement of FDP, and measurement method
#261Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain
#262Composition comprising an angiopoietin-4 fragment
#263METHODS FOR DIAGNOSIS OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
#264EXAMINATION METHOD TO DETERMINE CONTRACTION OR ACTIVITY OF DISEASES RELATED IMMUNE SYSTEM OR JOINT SYSTEM
#265Method for binding a recombinant polypeptide to a carrier
#266Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject
#267Method and Apparatus for Predicting Pharmacological Efficacy of Human Anti-TNFa Antibody Drug against Rheumatoid Arthritis
#268Methods of treating diseases
#269Use of gelsolin to diagnose and treat inflammatory diseases
#270ASSESSING RHEUMATOID ARTHRITIS
#271Methods and products for evaluating an immune response to a therapeutic protein
#272Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
#273Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
#274DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#275METABOLIC PROFILES
#276METHOD FOR PREDICTION OF RESPONSE TO RHEUMATOID ARTHRITIS THERAPEUTICS
#277Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
#278Rheumatoid Arthritis Test Method And Treating Method
#279Biomarkers for the Diagnosis of Autoimmune Disease
#280BIOMARKERS AND USES THEREOF
#281Compositions and methods for characterizing arthritic conditions
#282Method for improving immune system function by administering agents that inhibit DNA-dependent protein kinase-directed apoptosis
#283METHOD FOR ASSESSING INFLAMMATORY CONDITION
#284Naphthalene-based inhibitors of anti-apoptotic proteins
#285Methods for treating inflammatory bowel disease
#286GENE EXPRESSION MARKERS FOR PREDICTING RESPONSE TO INTERLEUKIN-6 RECEPTOR-INHIBITING MONOCLONAL ANTIBODY DRUG TREATMENT
#287Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#288AUTOIMMUNE DISEASE BIOMARKERS
#289Dissolved protein arthritis markers
#290METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK
#291Method for assaying keratan sulfate, assay kit therefor and method for detecting joint disease by using the same
#292EDTA Resistant S100A12 Complexes (ERAC)
#293Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
#294Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
#295GDF15 as a differential marker for spondyloarthropathy
#296DETECTION OF IFI16 IN BODY FLUIDS
#297Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
#298BIOLOGICAL MARKERS PREDICTIVE OF RHEUMATOID ARTHRITIS RESPONSE TO LYMPHOTOXIN ANTAGONISTS
#299ASSAY METHOD FOR ANTIBODIES AGAINST CYCLIC CITRULLINATED PEPTIDE
#300Methods and reagents for diagnosing rheumatoid arthrtis